Merck KGaA at JPMorgan Healthcare Conference Transcript
Good morning, everyone. Welcome to the Merck KGaA from Darmstadt, Germany presentation. I've got to get that clear. At the JPMorgan Healthcare Conference. I'm Richard Vosser, European pharma analyst with JPMorgan. It's my great pleasure to welcome the CEO, Belen Garijo, who is going to do the presentation. The Q&A is in this room. So we've got no problems with those logistics. So Belen, welcome to the conference.
Thank you very much. Thank you, Richard, and good morning, everyone. It's a pleasure to be here one more year, keeping the tradition of starting of the new year with the presentation at JPMorgan. So Happy New Year, everyone. I'm very pleased to be here.
So let me -- next, please. So let me start by stating and even, I would say, celebrating that we have left behind a very tough transition year in 2023. And now we are looking forward to the future with a strong confidence. And why is that? First of all
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |